Faculty Disclosures
| Anastasia Zekeridou, MD, PhD, FAAN |
The institution of Dr. Zekeridou has received research support from Roche/Genentech. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. Dr. Zekeridou has received intellectual property interests from a discovery or technology relating to health care. |
| Eoin P. Flanagan, MBBCh, FAAN |
The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities. |
| Stacey Clardy, MD, PhD, FAAN |
Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed. |
| Sean J. Pittock, MD, FAAN |
Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care. |
| Amy Kunchok, MBBS |
Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal . |
| Melissa A. Wright, MD |
Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . |
| Mayra Montalvo Perero, MD |
Dr. Montalvo Perero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG THERAPEUTICS. Dr. Montalvo Perero has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. |
| Grace Gombolay, MD, FAAN |
The institution of Dr. Gombolay has received research support from CDC. The institution of Dr. Gombolay has received research support from NIH. Dr. Gombolay has a non-compensated relationship as a Board of Trustee with National MS Society -Georgia chapter that is relevant to AAN interests or activities. |
| Dean M. Wingerchuk, MD, FAAN |
Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers. |
| Luis Querol, MD, PhD |
Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avilar. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocryst. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KPL. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lycia. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Querol has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB. The institution of Dr. Querol has received research support from ArgenX. |
| Michel Toledano, MD |
Dr. Toledano has nothing to disclose. |
| Chafic Y. Karam, MD |
Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alnylam. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvig. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied therapeutics. Dr. Karam has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intellia. Dr. Karam has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Karam has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. |
| Rebecca Traub, MD, FAAN |
Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice. |
| Amanda L. Piquet, MD, FAAN |
The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| Justin Abbatemarco, MD |
Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
| Kyle M. Blackburn, MD |
Dr. Blackburn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. |
| Andrew McKeon, MD |
The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care. |
| Marinos C. Dalakas, MD, FAAN |
Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols, . Dr. Dalakas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dysimmune Diseases Foundation. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurology (TAND). Dr. Dalakas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. |
| Shailee S. Shah, MD |
Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care. |
| Sarah F. Wesley, MD, MPH |
Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wesley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wesley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. |
| Jennifer McCombe, MD |
Dr. McCombe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. |
| Giovanna Manzano, MD |
Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead Sciences. Dr. Manzano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for InfuCare Rx. |
| Carlos A. Pardo-Villamizar, MD |
The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research . |
| Spencer Hutto, MD |
Dr. Hutto has nothing to disclose. |
| Adrian Budhram, MD |
Dr. Budhram has nothing to disclose. |
| Divyanshu Dubey, MD, FAAN |
The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. |
| Tammy L. Smith, MD, PhD |
Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca. |
| Sarosh R. Irani, MD, PhD, FRCP, FEAN |
Dr. Irani has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Argenex, Atheneum, AZ, Clarivate, IQVIA, BioHaven therapeutics. Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion US, Amgen, Argenx . Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. The institution of Dr. Irani has received research support from Amgen. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. |
| Hesham A. Abboud, MD |
Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care. |
| Marcus Vinicius R. Pinto, MD |
Dr. Pinto has nothing to disclose. |
| Kelsey Poisson, MD |
Dr. Poisson has nothing to disclose. |
| Jeffrey A. Allen, MD |
Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl behring. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson and Johnson. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dianthus. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Allen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Allen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for CSL behring. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Allen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Johnson and Johnson. |
| Amy M. Quek, MBBS |
The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. The institution of Dr. Quek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. |
| John Probasco, MD, FAAN |
Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |
| Sydney Lee, MD |
Dr. Lee has nothing to disclose. |
| Kristin M. Galetta, MD |
Dr. Galetta has received personal compensation in the range of $0-$499 for serving as a Speaker with Can Do MS. |
| Naveen K. Paramasivan, MD |
Dr. Paramasivan has nothing to disclose. |
| Sara Moss, MD |
Dr. Moss has nothing to disclose. |
| Thomas F. Scott, MD |
Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. |
| Alison M. Pack, MD, FAAN |
An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care. |
| Kejal Kantarci, MD |
The institution of Dr. Kantarci has received research support from Eli Lilly. The institution of Dr. Kantarci has received research support from NIH. The institution of Dr. Kantarci has received research support from ADDF. The institution of Dr. Kantarci has received research support from Eisai. The institution of Dr. Kantarci has received research support from BioArctic. |
| Rana K. Zabad, MD, FAAN |
Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals. |
| Ralf Gold, MD, FAAN |
Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen. |
| Mark Wainwright, MD, PhD, FAAN |
Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics. |
| Jesus Lovera, MD |
Dr. Lovera has nothing to disclose. |
| Nagagopal Venna, MBBS, FAAN |
Dr. Venna has nothing to disclose. |
| David F. Tang-Wai, MD, FRCPC |
Dr. Tang-Wai has nothing to disclose. |
| Tracey A. Milligan, MD, FAAN |
Dr. Milligan has received publishing royalties from a publication relating to health care. |
| Srikanth Muppidi, MD, FAAN |
Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for argenx. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra Pharma. Dr. Muppidi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizont Pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J & J pharma. Dr. Muppidi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus Pharma. Dr. Muppidi has received publishing royalties from a publication relating to health care. |
| Jeffrey W. Britton, MD, FAAN |
Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society. |
| John R. Absher, MD, FAAN |
Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehabilitation Alternative Services, Inc.. Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Butler, Means, Evins and Browne, P.A.. |
| Carolin Dohle, MD |
Dr. Dohle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion TPharmaceuticals. Dr. Dohle has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. |
| Andrew Knight |
Andrew Knight has nothing to disclose. |
| Gregory S. Day, MD, MSc, FAAN |
Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with 好色先生. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing 好色先生, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a 好色先生al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities. |
| Aiden Haghikia, MD |
Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. The institution of Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyverna. Dr. Haghikia has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuraxpharm. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Biogen. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Sanofi. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Novartis. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Merck Serono. Dr. Haghikia has received personal compensation in the range of $500-$4,999 for serving as a speaker with Celgene. |
| Christopher Schwarz |
The institution of Christopher Schwarz has received research support from NIH. |
| Andrew Solomon, MD, FAAN |
Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb. |
| Arun Venkatesan, MD, PhD |
Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD. |
| John N. Soltys, MD |
Dr. Soltys has nothing to disclose. |
| Ryan D. Walsh, MD |
Dr. Walsh has nothing to disclose. |
| Haatem M. Reda, MD |
Dr. Reda has nothing to disclose. |
| Derek Johnson, MD |
Dr. Johnson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Telix. |
| Samir Alkabie, MD, MSc |
Dr. Alkabie has nothing to disclose. |
| Murat Gokden |
Murat Gokden has nothing to disclose. |
| Brian J. Copeland, MD |
Dr. Copeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva Neurosciences. The institution of Dr. Copeland has received research support from Ipsen Biopharmaceuticals. |
| Keith Van Haren, MD |
Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. |
| Ariel Antezana, MD |
Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Antezana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. |
| David R. Benavides, MD, PhD, FAAN |
The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd. |
| Rajesh K. Gupta, MBBS |
Dr. Gupta has nothing to disclose. |
| Kristine H. O'Phelan, MD |
Dr. O'Phelan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bard Medical. Dr. O'Phelan has a non-compensated relationship as a DSMB member SIREN network with NIH/NINDS that is relevant to AAN interests or activities. |
| Benjamin H. Brinkmann, PhD |
Dr. Brinkmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Brinkmann has stock in Cadence Neuroscience. The institution of Dr. Brinkmann has received research support from Epilepsy Foundation of America. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from National Institutes of Health. The institution of Dr. Brinkmann has received research support from UNEEG A/S. The institution of Dr. Brinkmann has received research support from Seer Medical Pty. The institution of Dr. Brinkmann has received research support from Neurelis Inc. Dr. Brinkmann has received intellectual property interests from a discovery or technology relating to health care. |
| Federico Silva |
Federico Silva has nothing to disclose. |
| Timothy W. West, MD |
Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. West has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. |
| Robert L. Archer, MD, FAAN |
Dr. Archer has nothing to disclose. |
| Stephen L. Yates, PhD |
Dr. Yates has received personal compensation for serving as an employee of UCB Biosciences, Inc.. Dr. Yates has stock in UCB Biosciences, Inc.. |
| Scott M. Belliston, DO |
Dr. Belliston has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Ignacio Demey, MD, PhD |
Ignacio Demey, MD, PhD has received personal compensation for serving as an employee of IQVIA. |
| Hugo Botha, MD |
Dr. Botha has received research support from NIH. An immediate family member of Dr. Botha has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. |
| Shitiz K. Sriwastava, MBBS |
Dr. Sriwastava has nothing to disclose. |
| Nicholas Thompson |
The institution of Nicholas Thompson has received research support from EMD Serono. |
| Sarah Lapointe, MD |
Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lapointe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Lapointe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
| Catherine E. Otten, MD |
The institution of Dr. Otten has received research support from CDC. |
| Tirisham Gyang, MD |
Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. |
| Asaff Harel, MD |
Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. |
| Lily Pham, MD |
Dr. Pham has nothing to disclose. |
| Ahmed Z. Obeidat, MD, PhD |
Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for EMD Serono. Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi/Genzyme . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon pharmaceuticals . Dr. Obeidat has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sandoz. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Obeidat has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for EMD Serono. Dr. Obeidat has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/genzyme. Dr. Obeidat has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Horizon therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. The institution of Dr. Obeidat has received research support from NIH. The institution of Dr. Obeidat has received research support from NMSS and PCORI. Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Expert opinion and key opinion leader with MJH life sciences . Dr. Obeidat has received personal compensation in the range of $10,000-$49,999 for serving as a Faculty Speaker with CMSC. Dr. Obeidat has a non-compensated relationship as a Board member with CMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Editorial Board Member with IJMSC that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Reviewer Editor with Frontiers Neurology that is relevant to AAN interests or activities. Dr. Obeidat has a non-compensated relationship as a Board of Trustee Member with National MS Society that is relevant to AAN interests or activities. |
| Bhrugav G. Raval, MD |
Dr. Raval has nothing to disclose. |
| Alexander Carvajal- Gonzalez, MD, PhD |
Dr. Carvajal- Gonzalez has nothing to disclose. |
| Laura Cacciaguerra, MD, PhD |
Dr. Cacciaguerra has nothing to disclose. |
| Rodrigo Hasbun |
Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux. |
| Rachelle Dugue, MD, PhD |
Dr. Dugue has nothing to disclose. |
| Ilana L. Kahn, MD |
Dr. Kahn has nothing to disclose. |
| Jagkirat Singh, MBBS |
Dr. Singh has nothing to disclose. |
| Nidhiben A. Anadani, MD |
Dr. Anadani has nothing to disclose. |
| Lileth Joy H. Mondok, MD |
Dr. Mondok has nothing to disclose. |
| Ka-Ho Wong |
The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association. |
| Alexandra B. Kornbluh, MD |
Dr. Kornbluh has nothing to disclose. |
| Mariano Marrodan, MD |
Dr. Marrodan has nothing to disclose. |
| Jyh Yung Hor, MD |
Dr. Hor has nothing to disclose. |
| Julien Hebert, MD |
Dr. Hebert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Paladin Labs. Dr. Hebert has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gowling WLG. The institution of Dr. Hebert has received research support from Praxis Precision Medicine. |
| Alexandra Muccilli, MD |
Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Muccilli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Muccilli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. |
| Ashley E. Aaroe, MD |
Dr. Aaroe has received personal compensation in the range of $10,000-$49,999 for serving as a Delphi Panel Consultant with Advi. |
| Abdul Rahman Alchaki, MD |
Dr. Alchaki has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. |
| Kaylan Fenton |
Ms. Fenton has nothing to disclose. |
| Elizabeth Verter, MD |
Dr. Verter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Verter has received personal compensation in the range of $50,000-$99,999 for serving as a Fellow with National MS Society. |
| Guillermo Gonzalez-Manrique |
Guillermo Gonzalez-Manrique has nothing to disclose. |
| Lyda Osorio |
Lyda Osorio has nothing to disclose. |
| Jeremias Motte, MD |
The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum. |
| Beatriz Parra |
Beatriz Parra has nothing to disclose. |
| Burcu Zeydan, MD |
The institution of Dr. Zeydan has received research support from National Institutes of Health. |
| Kanika Sharma, MD |
Dr. Sharma has nothing to disclose. |
| Roohi Katyal, MD |
Dr. Katyal has nothing to disclose. |
| Kelsey M. Smith, MD |
The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals. |
| Kon Chu |
Kon Chu has nothing to disclose. |
| Jiraporn Jitprapaikulsan, MD |
Dr. Jitprapaikulsan has nothing to disclose. |
| Souhel Najjar, MD |
Dr. Najjar has nothing to disclose. |
| Jonathan Santoro, MD |
Dr. Santoro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Santoro has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cycle Pharma. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Santoro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Down Syndrome Society. |
| Michael C. Hunter, MD |
Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. |
| Johanna L. Rosenthal, MD |
Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Rosenthal with California Neurology Society. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Board of Directors Legislative Chairman4 with California Neurology Society. Dr. Rosenthal has received personal compensation in the range of $500-$4,999 for serving as a Board of Directors, Legislative Chair202 with California Neurology Society. |
| Kristen Fisher, DO |
Dr. Fisher has nothing to disclose. |
| Dana B. Harrar, MD |
The institution of Dr. Harrar has received research support from NIH. Dr. Harrar has received publishing royalties from a publication relating to health care. |
| Katherine A. Zarroli, MD |
Dr. Zarroli has nothing to disclose. |
| Sam Hooshmand, DO |
Dr. Hooshmand has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech USA. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Hooshmand has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics . Dr. Hooshmand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen . The institution of Dr. Hooshmand has received research support from Novartis . |
| Roberto Alejandro Cruz, MD |
The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AMGEN. The institution of Dr. Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. |
| Ahmad Mahadeen, MD |
Dr. Mahadeen has nothing to disclose. |
| Ryan Kammeyer, MD |
The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Kammeyer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ogborn-Mihm Trial Lawyers. The institution of Dr. Kammeyer has received research support from Rocky Mountain Multiple Sclerosis Center. |
| Claire E. Delpirou Nouh, MD |
The institution of Dr. Delpirou Nouh has received research support from Oklahomas Nathan Shock Center. Dr. Delpirou Nouh has a non-compensated relationship as a Volunteer/Board member with Oklahoma Alzheimer Association that is relevant to AAN interests or activities. |
| Rucha Bahekar, MBBS |
Dr. Bahekar has nothing to disclose. |
| Mark J. Kelly, MBBS |
The institution of Dr. Kelly has received research support from The Health Research Board / Wellcome Trust. |
| Heather Yong, MD |
Dr. Yong has nothing to disclose. |
| Soon-Tae Lee, MD, PhD |
Prof. Lee has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Piehealthcare. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salted. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. The institution of Prof. Lee has received research support from Roche. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care. |
| Sang Kun Lee, MD |
Prof. Lee has nothing to disclose. |
| Tatia Aprasidze |
Ms. Aprasidze has nothing to disclose. |
| Sarah E. Fredrich, MD |
Dr. Fredrich has nothing to disclose. |
| Seth A. Climans, MD |
Dr. Climans has nothing to disclose. |
| Ekta G. Shah, DO, MS |
Dr. Shah has nothing to disclose. |
| Anuja R. Patil, MD, DM |
Dr. Patil has nothing to disclose. |
| Alexander Sandweiss, MD, PhD |
Dr. Sandweiss has nothing to disclose. |
| John R. Mills, MD, PhD |
The institution of Dr. Mills has received research support from Werfen Diagnostics. Dr. Mills has received intellectual property interests from a discovery or technology relating to health care. |
| Jennifer H. Yang, MD |
Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Yang has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ Case Reports. The institution of Dr. Yang has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Yang has received research support from NIH. The institution of Dr. Yang has received research support from Rady Foundation. |
| Linus D. Sun, MD, PhD |
Dr. Sun has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Sun has stock in Denali Therapeutics. |
| Stefanie J. Rodenbeck, MD |
Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Rodenbeck has received personal compensation in the range of $500-$4,999 for serving as a interview appearance with TG Therapeutics. |
| Travis R. Kooima, MD |
Dr. Kooima has nothing to disclose. |
| Yihui Goh, MBBS |
Dr. Goh has nothing to disclose. |
| Yoonhyuk Jang, MD, PhD |
Mr. Jang has nothing to disclose. |
| David Acero-Garces, MD |
Dr. Acero-Garces has nothing to disclose. |
| Albert Aboseif, DO |
Dr. Aboseif has received research support from the Eugene & Marcia Applebaum Fellowship Grant. |
| Xiaoyang Li, MD |
Dr. Li has nothing to disclose. |
| Maria I. Reyes, MD |
Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. |
| Manali Desai, DO |
Dr. Desai has nothing to disclose. |
| Surendra Dasari |
Surendra Dasari has nothing to disclose. |
| Joseph C. LaPorta |
Mr. LaPorta has nothing to disclose. |
| Chirag S. Lalwani, MBBS |
Dr. Lalwani has nothing to disclose. |
| Varun Kannan, MD |
Dr. Kannan has nothing to disclose. |
| Binxia Yang |
Binxia Yang has nothing to disclose. |
| Sophie Binks, MD, MBBS, PhD |
The institution of Dr. Binks has received research support from Wellcome Trust. The institution of Dr. Binks has received research support from PetSavers. The institution of Dr. Binks has received research support from PetPlan. The institution of Dr. Binks has received research support from NIHR. The institution of Dr. Binks has received research support from Morris Animal Foundation. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ECTRIMS. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with Vetmeduni Wien. Dr. Binks has received personal compensation in the range of $0-$499 for serving as a Speaker with ANA. Dr. Binks has a non-compensated relationship as a Speaker with Encephalitis Society UK that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Scientific Panel Member with Encephalitis International that is relevant to AAN interests or activities. Dr. Binks has a non-compensated relationship as a Editorial Fellow with JAMA Neurology that is relevant to AAN interests or activities. |
| Yahel Segal, MD |
Dr. Segal has nothing to disclose. |
| Caleb R. McEntire, MD |
Dr. McEntire has nothing to disclose. |
| Ronak K. Kapadia, MD |
Dr. Kapadia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics/Amgen. |
| Leigh N. Sepeta, PhD |
Dr. Sepeta has received personal compensation in the range of $500,000-$999,999 for serving as a Grant PI with Nih. Dr. Sepeta has a non-compensated relationship as a Special volunteer with Nih that is relevant to AAN interests or activities. |
| Felipe Jones, MD |
Dr. Jones has nothing to disclose. |
| Jonathan Yarimi, MD |
Dr. Yarimi has nothing to disclose. |
| Nathaniel P. Rogers, Jr., MD |
Dr. Rogers has nothing to disclose. |
| Abby Scurfield, MD |
Dr. Scurfield has nothing to disclose. |
| Mahmoud Elkhooly, MD |
Dr. Elkhooly has nothing to disclose. |
| Soo Hyun Ahn, MD |
Dr. Ahn has nothing to disclose. |
| Madison Grindstaff, DO |
Dr. Grindstaff has nothing to disclose. |
| Dhara Mehta, DO |
Dr. Mehta has nothing to disclose. |
| Jamie H. Aldridge, PhD, PA |
Dr. Aldridge has received personal compensation for serving as an employee of argenx. Dr. Aldridge has or had stock in argenx. |
| Monica S. Arroyo, MD |
Dr. Arroyo has nothing to disclose. |
| Mostafa Hotait, MD |
Dr. Hotait has nothing to disclose. |
| Elise Johnson, MD |
Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. |
| Alec Friedman, MD |
Dr. Friedman has nothing to disclose. |
| Helen Wu, MD, PhD |
Dr. Wu has nothing to disclose. |
| Luke T. Massaro, MD |
Dr. Massaro has nothing to disclose. |
| Sulafa G. Saffarini, MD |
Dr. Saffarini has nothing to disclose. |
| Athena Dao, MD |
Dr. Dao has nothing to disclose. |
| Jhon E. Bocanegra-Becerra |
Mr. Bocanegra-Becerra has nothing to disclose. |
| Ayush Gupta, MD |
Dr. Gupta has nothing to disclose. |
| Amy Young, MD |
Dr. Young has nothing to disclose. |
| Zeinab Awada, MD |
Dr. Awada has nothing to disclose. |
| Jairo Lizarazo Niño |
Jairo Lizarazo Niño has nothing to disclose. |
| Laura J. Green, MD |
Dr. Green has nothing to disclose. |
| Jonathan Trout, MD |
Dr. Trout has nothing to disclose. |
| Andrew Silverman, MD |
Dr. Silverman has nothing to disclose. |
| Amro E. AbuShanab, MBBS |
Dr. AbuShanab has nothing to disclose. |
| Simranpreet Singh, MD |
Dr. Singh has nothing to disclose. |
| Prashanth Rajarajan, MD, PhD |
Dr. Rajarajan has nothing to disclose. |
| Christoper A. Alarcon Ruiz, MD |
Dr. Alarcon Ruiz has received research support from Universidad Científica del Sur. |
| FNU Shivangi, MBBS |
Dr. Shivangi has nothing to disclose. |
| Bijoya Basu |
Miss Basu has nothing to disclose. |
| Maria de Los Angeles Alvarez Falcon |
Ms. Alvarez Falcon has nothing to disclose. |
| Rutu Patel, PA |
Ms. Patel has nothing to disclose. |
| Sophia F. Damman, MD |
Ms. Damman has nothing to disclose. |
| Adam Goldman-Yassen |
Adam Goldman-Yassen has nothing to disclose. |
| Leland Barnard |
Leland Barnard has nothing to disclose. |
| Su Yee Mon |
Su Yee Mon has nothing to disclose. |
| Tobias Hegelmaier |
Tobias Hegelmaier has nothing to disclose. |
| Pallab Sarker |
Pallab Sarker has nothing to disclose. |
| Roland Schroers |
Roland Schroers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KYVERNA. |
| Madeleine H. McLaughlin, MD |
Dr. Hebert has nothing to disclose. |
| Prabhumallikarjun Patil, MD |
Dr. Patil has nothing to disclose. |
| Danielle Pitter, MD |
Dr. Pitter has nothing to disclose. |
| Pooja Patel, DO |
Dr. Patel has nothing to disclose. |
| Damlanur Kaval, MD |
Dr. Kaval has nothing to disclose. |
| Panayotes Demakakos |
Panayotes Demakakos has nothing to disclose. |
| Adam Handel |
The institution of Adam Handel has received research support from Medical Research Council (UK). The institution of Adam Handel has received research support from UCB-Pharma. The institution of Adam Handel has received research support from MyAware. |
| Cole M. Cimoch |
Mr. Cimoch has nothing to disclose. |
| Samhitha Rai |
Miss Rai has nothing to disclose. |
| Kathy L. Niu, MD |
Dr. Niu has nothing to disclose. |
| Levi C. Shelton, MD |
Dr. Shelton has nothing to disclose. |
| Amanda F. Abuaf, MD |
Dr. Abuaf has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Viswas V. Dayal, MD |
Dr. Dayal has nothing to disclose. |
| Andreu Vilaseca-Jolonch, MD |
Dr. Vilaseca-Jolonch has received research support from Fundación Martín Escudero. |
| Thomas C. Varkey, MD |
Dr. Varkey has nothing to disclose. |
| Aiswarya Raj, MBBS |
Dr. Raj has nothing to disclose. |
| Arman Saied, MD |
Dr. Saied has nothing to disclose. |
| Mhd Majd Mardini, MD |
Dr. Mardini has nothing to disclose. |
| Soo Jean Shin |
Ms. Shin has nothing to disclose. |
| Sarika Mutyala, MBBS |
Dr. Mutyala has nothing to disclose. |
| Michael L. Miller, MD, PhD |
Dr. Miller has nothing to disclose. |
| Geoffrey Istas |
Geoffrey Istas has or had stock in Argenx.Geoffrey Istas has received intellectual property interests from a discovery or technology relating to health care. |
| Tatchaporn Ongphichetmetha |
Miss Ongphichetmetha has nothing to disclose. |
| Anusha Akhai, MD, MBBS |
Dr. Akhai has nothing to disclose. |
| Aishwarya J, MD |
Ms. J has nothing to disclose. |
| Jana Zschüntzsch, MD, PhD |
Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kedrion. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Zschüntzsch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Zschüntzsch has received research support from Argenx. The institution of Dr. Zschüntzsch has received research support from European commission. The institution of Dr. Zschüntzsch has received research support from UCB. The institution of Dr. Zschüntzsch has received research support from GB-A. |
| Danielle B. Dilsaver, MS |
Miss Dilsaver has nothing to disclose. |
| YOON HEE SHIN |
Ms. SHIN has nothing to disclose. |
| P Powell, PhD |
Dr. Powell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IQVIA. Dr. Powell has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Powell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for KMC Health Care. Dr. Powell has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Quality of Life Research. The institution of Dr. Powell has received research support from FSHD Society. The institution of Dr. Powell has received research support from EuroQol Research Foundation. The institution of Dr. Powell has received research support from AstraZeneca. The institution of Dr. Powell has received research support from KMC Healthcare. The institution of Dr. Powell has received research support from Duchenne UK. The institution of Dr. Powell has received research support from Sanofi. |
| Mohammad Munim Zahoor, MD |
Mr. Zahoor has nothing to disclose. |
| Julian A. Rivillas, MD |
Dr. Rivillas has nothing to disclose. |
| Christine Strippel, MD |
Dr. Strippel has nothing to disclose. |
| Akash Rawat, MD, MBBS |
Dr. Rawat has nothing to disclose. |
| Sarah Hoffmann, MD, PhD |
Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Prof. Hoffmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Prof. Hoffmann has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. The institution of Prof. Hoffmann has received research support from Janssen. The institution of Prof. Hoffmann has received research support from Argenx. |
| B D. Wagner, Jr., MD |
Dr. Wagner has nothing to disclose. |
| Khaled Zammar, MD, MSc |
Dr. Zammar has nothing to disclose. |
| Hanna Retallack, MD, PhD |
No disclosure on file
|
| Apurva H. Patel, MD |
Dr. Patel has nothing to disclose. |
| Nivethitha Manohar, MD |
Dr. Manohar has nothing to disclose. |
| Matthew J. Viereck, MD |
Dr. Viereck has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome Therapeutics. |
| Courtney Huval, MD |
Dr. Huval has nothing to disclose. |
| Liz C. Ballinger, MD, PhD |
Dr. Ballinger has nothing to disclose. |
| Natanya Mishal, MD |
Dr. Mishal has nothing to disclose. |
| Vera Nemsadze, MD |
Dr. Nemsadze has nothing to disclose. |
| Jerilyn Summay, MD |
Dr. Summay has nothing to disclose. |
| Usama Khan, MD |
Dr. Khan has nothing to disclose. |
| Sai Pratibha Yandamuri |
Miss Yandamuri has nothing to disclose. |
| Majd A. AbuAlrob, MD |
Dr. AbuAlrob has nothing to disclose. |
| Michael J. McGill, MD |
Dr. McGill has nothing to disclose. |
| Kelli Manikowski, DO |
Mrs. Manikowski has nothing to disclose. |
| Beatriz Garcia Cañibano, MD |
Dr. Garcia Cañibano has nothing to disclose. |
| Amy J. Lin, MD |
Dr. Lin has nothing to disclose. |
| Luis A. Diaz Tejada |
Mr. Diaz Tejada has a non-compensated relationship as a President with SIGN UPCH that is relevant to AAN interests or activities. |
| Ilaiyabharathi Thulasimani |
Mr. Thulasimani has nothing to disclose. |
| Prateek Thakur |
Mr. Thakur has nothing to disclose. |
| Benjamin Knier |
Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Knier has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Dr. Knier has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. The institution of Dr. Knier has received research support from Deutsche Forschungsgemeinschaft. |
| Naji Gehchan |
Dr. Gehchan has received personal compensation for serving as an employee of Kyverna Tx. Dr. Gehchan has received personal compensation for serving as an employee of Eli Lilly. Dr. Gehchan has stock in Eli Lilly. |
| Xavier Grandes |
Mr. Grandes has nothing to disclose. |
| Chris Pashos |
Mr. Pashos has received personal compensation for serving as an employee of argenx. |
| Filip Eftimov, MD, PhD |
Dr. Eftimov has nothing to disclose. |
| Waleed Alon II |
Mr. Alon has nothing to disclose. |
| Hanna Malik, DO |
Hanna Malik, DO has nothing to disclose. |
| Muhammad Moiz Javed, MD |
Dr. Javed has nothing to disclose. |
| Jasmin Kumar |
Miss Kumar has nothing to disclose. |
| Drishtdeum Malik |
Mr. Malik has nothing to disclose. |
| Nabeeha Noor, MD |
Ms. Noor has nothing to disclose. |
| Abdallah HUSSEIN, MD |
Dr. HUSSEIN has nothing to disclose. |
| Alice Yu |
Miss Yu has nothing to disclose. |
| Nicole J. Al Alam Rabie |
Nicole J. Al Alam Rabie has nothing to disclose. |
| Justin T. Levinsky, MHSc |
Mr. Levinsky has nothing to disclose. |
| Richard Wennberg, MD, PhD |
Dr. Wennberg has nothing to disclose. |
| Mashoor Al Ahammed |
Mr. Ahammed has nothing to disclose. |
| Nancy I. Di Salvo, Patient Advocate |
Miss Di Salvo has nothing to disclose. |
| Silvana B. De Lorenzo, PhD |
Dr. De Lorenzo has nothing to disclose. |
| Grace K. Cedeño, MD |
Dr. Cedeño has nothing to disclose. |
| Shankar Biswas, MD |
Dr. Biswas has nothing to disclose. |
| SAI VENKATA MANOJ KOTHARU, MBBS |
Dr. KOTHARU has nothing to disclose. |
| Sindhu Vasireddy, MD |
Dr. Vasireddy has nothing to disclose. |
| Bradley Hunter, MD |
Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kite Pharma. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Johnson & Johnson. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Caribou Biosciences. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for In8 Bio. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Hunter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseida Therapeutics . Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kite Pharma. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie/Genmab. Dr. Hunter has stock in Actinium Pharmaseuticals. The institution of Dr. Hunter has received research support from Johnson & Johnson. |
| Nirumal Khumar, DM neurology |
Dr. Khumar has nothing to disclose. |
| Saad Ali, MD |
Dr. Ali has nothing to disclose. |
| Charlotte Schubert, MD |
Mrs. Schubert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Alexion, Johnson&Johnson. Mrs. Schubert has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion, Argenx. |
| Sathish K. Mallikarjuna, MD |
Dr. Mallikarjuna has nothing to disclose. |
| Yashasvi Srivastava, MBBS |
Ms. Srivastava has nothing to disclose. |
| Neelakandan Sivathanu, MBBS |
Mr. Sivathanu has nothing to disclose. |
| Nooka Monika Reddy, MD |
Dr. Reddy has nothing to disclose. |
| Justin Chou, PhD |
Dr. Chou has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Chou has received intellectual property interests from a discovery or technology relating to health care. |
| Christian R. Schultze-Florey, MD |
Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pierre Fabre. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gilead. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mikrogen. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson&Johnson. Dr. Schultze-Florey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. |
| Francis A. Ayuk, MD |
Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite/Giliead. Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miltenyi Biomedicine. Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Prof. Ayuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Therakos. The institution of Prof. Ayuk has received research support from Therakos. The institution of Prof. Ayuk has received research support from Neovii. |
| Bryan Ceronie, MBBS |
No disclosure on file
|
| Marie Luise Hütter-Krönke, MD |
Dr. Hütter-Krönke has nothing to disclose. |
| Osama Al-Dalahmah |
No disclosure on file
|
| Saman Haghighi |
Saman Haghighi has nothing to disclose. |
| Madison Sullivan, Medical Student |
Ms. Sullivan has nothing to disclose. |
| Dena Grayson |
Dr. Grayson has received personal compensation for serving as an employee of Kyverna Therapeutics. |
| Shouvonik Sengupta, PhD |
Dr. Sengupta has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Sengupta has or had stock in Kyverna Therapeutics. An immediate family member of Dr. Sengupta has or had stock in Kyverna Therapeutics. |
| John Sun, PhD |
Dr. Sun has received personal compensation for serving as an employee of Kyverna Therapeutics, Inc. |
| Xue Han |
Xue Han has received personal compensation for serving as an employee of Kyverna. The institution of Xue Han has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Kyverna. |
| Paul Kent, MD, PhD |
Dr. Kent has nothing to disclose. |
| Marylin H. Ortiz, MD |
No disclosure on file
|
| Abhishek Malhotra, MD |
Dr. Malhotra has nothing to disclose. |
| Haroon Z. Ahmad, MD |
Dr. Ahmad has nothing to disclose. |
| Luis A. Compres Brugal, MD |
Dr. Compres Brugal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. |
| Meghan Mack, MD |
Dr. Mack has nothing to disclose. |
| Ryan Coburn, MD |
Dr. Coburn has nothing to disclose. |
| Adam Dinoff, MD |
Dr. Dinoff has nothing to disclose. |
| Ahmad Abbas, MD |
Dr. Abbas has nothing to disclose. |
| Maren Johnson, MS |
Dr. Johnson has nothing to disclose. |
| Ala E. Shaban, MD |
Dr. Shaban has nothing to disclose. |
| Bayan Alqtishat, MD |
Dr. Alqtishat has nothing to disclose. |
| Sabeen Wazir, OMS-I |
Miss Wazir has nothing to disclose. |
| Antero Cubas, Jr. |
Mr. Cubas has nothing to disclose. |
| Nuria A. Rodriguez Aguilar, Jr. |
Miss Rodriguez Aguilar has nothing to disclose. |
| Maya U. De Belder, PhD |
Mrs. De Belder has received personal compensation for serving as an employee of Argenx. Mrs. De Belder has or had stock in argenx. |
| Yanira B. Nuñez Ramirez |
Dr. Nuñez Ramirez has nothing to disclose. |
| Ritesh R. Baddam, MD |
Dr. Baddam has nothing to disclose. |
| Maxim Dragoun, MD |
Dr. Dragoun has nothing to disclose. |
| madelyn p. pascual, MD |
Dr. pascual has nothing to disclose. |
| Sahithi Avva |
Sahithi Avva has nothing to disclose. |
| Aayush R. Kapoor, Medical Student (MBBS) |
Mr. Kapoor has received research support from Indian Council of Medical Research. |
| Sarang Perumal, MD |
Dr. Perumal has nothing to disclose. |
| Catherine Rojvirat, MD, PhD |
Dr. Rojvirat has nothing to disclose. |
| Chaoyang Wang, MBBS |
Dr. Wang has nothing to disclose. |
| Sarah C. Anderson, BSc, MBChB |
Dr. Anderson has nothing to disclose. |
| Divyanshu Chopra, MD |
Dr. Chopra has nothing to disclose. |
| Frank A. Trujillo, MD |
Dr. Trujillo has nothing to disclose. |
| Avegeene Paulino, MD |
Miss Paulino has nothing to disclose. |
| Mara Cohen, MD |
Dr. Cohen has nothing to disclose. |
| Farid Fabricio Rojas, Jr. |
Mr. Rojas has nothing to disclose. |
| Annie Lin, BA |
Miss Lin has nothing to disclose. |
| Jessica Benson |
Miss Benson has nothing to disclose. |
| Richard Sperry |
Mr. Sperry has received personal compensation for serving as an employee of GBS CIDP Foundation International. Mr. Sperry has received personal compensation in the range of $0-$499 for serving as a Consultant for Dianthus Therapeutics. The institution of Mr. Sperry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Mr. Sperry has received personal compensation in the range of $0-$499 for serving as a Survey Respondent with Rare Patient Voice. |
| Thomas Rossor, MD, PhD |
Dr. Rossor has nothing to disclose. |
| Andrea Stabile, MD |
Dr. Stabile has nothing to disclose. |
| Jade Thomas, DO |
Jade Thomas, DO has nothing to disclose. |
| Erin Moynihan, NP |
Ms. Moynihan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Ms. Moynihan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . |
| Kasyap Kondury |
Kasyap Kondury has nothing to disclose. |
| Kyoko Fukahori |
Kyoko Fukahori has nothing to disclose. |
| Lydia Ta, Medical Student (DO) |
Miss Ta has nothing to disclose. |
| Ameer Kakaje, MD |
Dr. Kakaje has nothing to disclose. |
| Sisi Xu, DO |
Dr. Xu has nothing to disclose. |
| Katherine Jordak, Medical Student |
Ms. Jordak has nothing to disclose. |
| Sakshi Sharma |
Miss Sharma has nothing to disclose. |
| Rushil Pithia |
Mr. Pithia has nothing to disclose. |
| John M. Thomas |
Mr. Thomas has nothing to disclose. |
| Sriya Parchuri |
Ms. Parchuri has nothing to disclose. |
| Hannah Stokan, BS |
Ms. Stokan has nothing to disclose. |
| Ram Polavarapu |
Mr. Polavarapu has nothing to disclose. |
| Kayla Grundman, CRC |
Miss Grundman has nothing to disclose. |
| Samantha O'Dell, BA, CRC |
Mrs. O'Dell has nothing to disclose. |
| Glennis T. Ayuk, MD |
Dr. Ayuk has nothing to disclose. |
| Christopher Kleefisch, MD |
Dr. Kleefisch has nothing to disclose. |
| Nithya S. Thangathiruppathi, Medical Student |
Ms. Thangathiruppathi has nothing to disclose. |
| Alexis Navarro |
Miss Navarro has nothing to disclose. |
| John Michael L. Reyes, MD |
Dr. Reyes has nothing to disclose. |
| Christine Bryant |
Dr. Bryant has received personal compensation for serving as an employee of Kyverna Therapeutics. Dr. Bryant has or had stock in Kyverna Therapeutics. |
| Michael Alexander Feijoo Jaramillo, Student |
Mr. Feijoo Jaramillo has nothing to disclose. |
| Susan Ellor, MD, PhD |
No disclosure on file
|
| Zohreh Akhavan Aghdam, PhD |
Mr. Akhavan Aghdam has received personal compensation for serving as an employee of argenx. Mr. Akhavan Aghdam has or had stock in argenx. |
| Siddharth Nara, MD |
The institution of Mr. Nara has received research support from Academies of Loudoun. Mr. Nara has a non-compensated relationship as a Student Researcher with Academies of Loudoun that is relevant to AAN interests or activities. |
| Sophia I. Padrón, Student |
Miss Padrón has nothing to disclose. |
| Amanda N. Foley |
Ms. Foley has or had stock in NIO.Ms. Foley has or had stock in Chargepoint.Ms. Foley has received research support from Kenneth A Suarez Research Fellowship. |
| Kyle G. Alexander, MD |
Dr. Alexander has nothing to disclose. |
| Lis Puga, PhD |
Dr. Puga has received personal compensation for serving as an employee of Patvocates. The institution of Dr. Puga has received research support from GBS CIDP Foundation International. |
| Jean-Philippe PLANCON, Patient representative |
Mr. PLANCON has nothing to disclose. |
| Nirohshah Trialonis-Suthakharan, MSc |
Mrs. Trialonis-Suthakharan has received personal compensation for serving as an employee of Patvocates. The institution of Mrs. Trialonis-Suthakharan has received research support from GBS CIDP Foundation International. |
| Andrew Liang |
Mr. Liang has nothing to disclose. |
| Ramalakshmi Neeharika Sriram, MD |
No disclosure on file
|
| Aditi Haribhakti, PharmD |
Dr. Haribhakti has nothing to disclose. |
| Karah A. Nuckles, MD |
Dr. Nuckles has nothing to disclose. |
| Jaclyn T. Aldrich, PhD |
Dr. Aldrich has nothing to disclose. |
| Jelena Jovanovic |
Dr. Jovanovic has received personal compensation for serving as an employee of IQVIA. Dr. Jovanovic has or had stock in IQVIA. |
| Nafiza Meher |
Ms. Meher has nothing to disclose. |
| Amandine Roure |
Ms. Roure has nothing to disclose. |
| Akemi Elguea |
Ms. Elguea has nothing to disclose. |
| Ria Mishra |
Miss Mishra has nothing to disclose. |
| Devanshu Raval, MBBS |
Mr. Raval has nothing to disclose. |
| Chris Ouellette, MD |
Dr. Ouellette has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Euroimmun. Dr. Ouellette has received research support from Oxford Immunotec. Dr. Ouellette has received publishing royalties from a publication relating to health care. |
| Caridad Abud |
Mrs. Abud has nothing to disclose. |
| Grace Lee, DO |
Miss Lee has nothing to disclose. |
| Victoria Dai |
An immediate family member of Ms. Dai has received personal compensation for serving as an employee of Z-Ply Corporation. An immediate family member of Ms. Dai has received personal compensation for serving as an employee of Empire State Piping. An immediate family member of Ms. Dai has received personal compensation for serving as an employee of Collective Playground Inc.. An immediate family member of Ms. Dai has received personal compensation for serving as an employee of Atlantic Collective Inc.. An immediate family member of Ms. Dai has received personal compensation for serving as an employee of Transperfect. Ms. Dai has or had stock in Lexicon Pharmaceuticals.Ms. Dai has or had stock in Microsoft.Ms. Dai has or had stock in Apple.Ms. Dai has or had stock in Uber. An immediate family member of Ms. Dai has or had stock in Alexion Pharmaceuticals.Ms. Dai has or had stock in Delta Air Lines. An immediate family member of Ms. Dai has or had stock in iShares National Muni Bond ETF.Ms. Dai has or had stock in HCA Healthcare.Ms. Dai has or had stock in NextEra Energy.Ms. Dai has or had stock in Chegg.Ms. Dai has or had stock in IBEX.Ms. Dai has or had stock in Bandwidth.Ms. Dai has or had stock in Illumina.Ms. Dai has or had stock in iShares National Muni Bond ETF.Ms. Dai has or had stock in Etsy.Ms. Dai has or had stock in Equinix.Ms. Dai has or had stock in Tesla.Ms. Dai has or had stock in NIO.Ms. Dai has or had stock in NextCure.Ms. Dai has or had stock in Amgen.Ms. Dai has or had stock in Personalis.Ms. Dai has or had stock in Catalent.Ms. Dai has or had stock in Fiesta Restaurant Group.Ms. Dai has or had stock in Las Vegas Sands.Ms. Dai has or had stock in iShares MSCI Emerging Markets ETF.Ms. Dai has or had stock in NCR Voyix Corporations.Ms. Dai has or had stock in NCR Voyix Corporation.Ms. Dai has or had stock in MidCap Financial.Ms. Dai has or had stock in Surgery Partners.Ms. Dai has or had stock in Acres Commercial Realty.Ms. Dai has or had stock in AT&T.Ms. Dai has or had stock in State Street Energy Select Sector SPDR ETF.Ms. Dai has or had stock in WisdomTree U.S. Efficient Core Fund.Ms. Dai has or had stock in MongoDB.Ms. Dai has or had stock in Vanguard S&P500 ETF.Ms. Dai has or had stock in SPDR S&P 500 ETF Trust. An immediate family member of Ms. Dai has or had stock in Rigetti Computing. An immediate family member of Ms. Dai has or had stock in Robinhood Markets. An immediate family member of Ms. Dai has or had stock in Sandisk. An immediate family member of Ms. Dai has or had stock in Solaredge Technologies. An immediate family member of Ms. Dai has or had stock in SS SPDR SP Biotech ETF. An immediate family member of Ms. Dai has or had stock in Super Micro Computer. An immediate family member of Ms. Dai has or had stock in Taiwan S Manufacturing ADR. An immediate family member of Ms. Dai has or had stock in Terawulf. An immediate family member of Ms. Dai has or had stock in Tesla. An immediate family member of Ms. Dai has or had stock in USA Rare Earth. An immediate family member of Ms. Dai has or had stock in Iren. An immediate family member of Ms. Dai has or had stock in Lumentum Holdings. An immediate family member of Ms. Dai has or had stock in Meta Platforms. An immediate family member of Ms. Dai has or had stock in Micron Technology. An immediate family member of Ms. Dai has or had stock in Microsoft . An immediate family member of Ms. Dai has or had stock in NVDIA. An immediate family member of Ms. Dai has or had stock in OKLO. An immediate family member of Ms. Dai has or had stock in Ondas Holdings. An immediate family member of Ms. Dai has or had stock in Ondas. An immediate family member of Ms. Dai has or had stock in Oracle. An immediate family member of Ms. Dai has or had stock in Palantir . An immediate family member of Ms. Dai has or had stock in Advncd Micro D. An immediate family member of Ms. Dai has or had stock in Arm Hldgs. An immediate family member of Ms. Dai has or had stock in AST Spacemobile. An immediate family member of Ms. Dai has or had stock in Bloom Energy. An immediate family member of Ms. Dai has or had stock in Circle Internet Group. An immediate family member of Ms. Dai has or had stock in Coinbase Global. An immediate family member of Ms. Dai has or had stock in Direxion Daily Semicon. An immediate family member of Ms. Dai has or had stock in Eli Lilly. An immediate family member of Ms. Dai has or had stock in Intel Corp. An immediate family member of Ms. Dai has or had stock in Adobe. An immediate family member of Ms. Dai has or had stock in Advncd Micro D. An immediate family member of Ms. Dai has or had stock in Alibaba Group Holding. An immediate family member of Ms. Dai has or had stock in Alphabet Inc. An immediate family member of Ms. Dai has or had stock in Amazon. An immediate family member of Ms. Dai has or had stock in Amgen. An immediate family member of Ms. Dai has or had stock in Apple. An immediate family member of Ms. Dai has or had stock in Applied Material. An immediate family member of Ms. Dai has or had stock in Applovin. An immediate family member of Ms. Dai has or had stock in Ast Spacemobile. |
| Jay Desai, BS |
Mr. Desai has nothing to disclose. |
| Rahul Sinha, MD |
Dr. Sinha has nothing to disclose. |
| Emily Virag, Medical Student |
Ms. Virag has nothing to disclose. |
| Katerina Nastea, MA |
Ms. Nastea has nothing to disclose. |
| Sebastian Jimenez, BS |
Mr. Jimenez has nothing to disclose. |
| Christoph Schaefers, MD |
Dr. Schaefers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Stemline. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oncopeptides. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GSK. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen-Cilag. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Schaefers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. |
| Nur Dizdar, MD, FEBNM |
Mrs. Dizdar has nothing to disclose. |
| Vanessa Pazdernik, MS |
Ms. Pazdernik has nothing to disclose. |
| Paulina Ciccone |
Miss Ciccone has nothing to disclose. |
| Saeed Asiry, MD |
Dr. Asiry has nothing to disclose. |
| Ana Lia Flavia |
Miss Flavia has nothing to disclose. |
| Liah C. Carrasco Ortíz |
Mrs. Carrasco Ortíz has nothing to disclose. |
| Mabel Santana |
Ms. Santana has nothing to disclose. |
| Karina Mendez De Sena |
Ms. Mendez De Sena has nothing to disclose. |
| Alfida L. Fernandez |
Miss Fernandez has nothing to disclose. |
| Elianna M. Reyes, MS3 |
Miss Reyes has nothing to disclose. |
| Laura A. Guerrero |
Ms. Guerrero has nothing to disclose. |
| Carla Alvarez Gonzalez |
Miss Alvarez Gonzalez has nothing to disclose. |
| María L. Andino, Student |
Ms. Andino has nothing to disclose. |
| Catherine Dominguez |
Ms. Dominguez has nothing to disclose. |
| Thomas V. Varghese, Jr., MD, MS, MBA |
Dr. Varghese has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Surgeons. |
| Adnan Ismail |
Mr. Ismail has nothing to disclose. |
| Anagha Shankar |
Miss Shankar has nothing to disclose. |
| Yuvraj Pathria |
Mr. Pathria has nothing to disclose. |
| Omar Nadeem, MD |
An immediate family member of Dr. Nadeem has received personal compensation for serving as an employee of Sanofi. Dr. Nadeem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JNJ. Dr. Nadeem has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GPCR therapeutics. Dr. Nadeem has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. Nadeem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. An immediate family member of Dr. Nadeem has or had stock in Sanofi. The institution of Dr. Nadeem has received research support from JNJ. The institution of Dr. Nadeem has received research support from BMS. |
| Bhavya Chadalavada, MD |
Dr. Chadalavada has nothing to disclose. |
| MIna Afsheen |
Ms. Afsheen has nothing to disclose. |
| Hiba Zainab, MD |
Mrs. Zainab has nothing to disclose. |
| Gloria Sura, MD |
Dr. Sura has nothing to disclose. |
| Alfredo E. Escarate Curi |
Mr. Escarate Curi has nothing to disclose. |
| Valery Vargas |
Miss Vargas has nothing to disclose. |
| Alexandra Julieta Romero Soto, Medical student |
Miss Romero Soto has nothing to disclose. |
| Gemeng Zhang, PhD |
Mr. Zhang has nothing to disclose. |
| Shayan Monabbati, PhD |
Dr. Monabbati has received intellectual property interests from a discovery or technology relating to health care. |
| Miguel A. Vences, MD |
Dr. Vences has nothing to disclose. |
| ANASTASIA N. TAKTIKOU, MSc |
Miss TAKTIKOU has received personal compensation for serving as an employee of IQVIA. |
| Meredith Dever, MPH |
Ms. Dever has nothing to disclose. |
| Jennifer Koop, PhD |
The institution of Dr. Koop has received research support from Bezos Family Foundation. |
| Eswar Damaraju, MS |
Mr. Damaraju has nothing to disclose. |
| Megan C. Freeman, MD, PhD |
Dr. Freeman has nothing to disclose. |
| Asimina Papadimitriou, MSc |
Ms. Papadimitriou has received personal compensation for serving as an employee of IQVIA. |
| Kartik Reddy, MD, MSCR |
Dr. Reddy has nothing to disclose. |
| Amy E. Stone, PhD |
Dr. Stone has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for W.W. Norton. |
| Sravya Kondrakunta, PhD |
Dr. Kondrakunta has nothing to disclose. |
| TeApatuoterangi A. McCrea, MBBS |
Dr. McCrea has nothing to disclose. |
| Catherine Wu, BA |
Ms. Wu has nothing to disclose. |
| Michael Basso, PhD |
Dr. Basso has nothing to disclose. |
| Simran Arora, MBBS |
Dr. Arora has nothing to disclose. |
| Anthony Dang |
Mr. Dang has nothing to disclose. |
| John Mackenzie, DO |
Dr. Mackenzie has nothing to disclose. |
| Camille Wilson, PhD |
The institution of Dr. Wilson has received research support from Nationwide Children's Hospital. |
| Femke De Ruyck, Ir |
Mrs. De Ruyck has received personal compensation for serving as an employee of argenx. Mrs. De Ruyck has or had stock in argenx. |
| Bryan Lanzman, MD |
Dr. Lanzman has nothing to disclose. |
| Desiree Gneissl, PhD |
Dr. Gneissl has nothing to disclose. |
| Daniel A. Godoy, Sr., MD |
Prof. Godoy has nothing to disclose. |
| Sarah S. Nikiforow, MD, PhD |
Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for A2 Bio. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara. Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Iovance. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pierre-Fabre. Dr. Nikiforow has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. Dr. Nikiforow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. |
| Anna Lizza s. Manalac, MD |
Dr. Manalac has nothing to disclose. |
| Luke Christenson |
Mr. Christenson has nothing to disclose. |
| Kenneth J. Lim, MBBS |
Dr. Lim has nothing to disclose. |
| Xinyi Jing, MD |
Dr. Jing has nothing to disclose. |
| Irene Ghobrial, MD |
An immediate family member of Dr. Ghobrial has received personal compensation for serving as an employee of Disc Medicine . Dr. Ghobrial has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regeneron . Dr. Ghobrial has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron . Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Ghobrial has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ghobrial has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kite. Dr. Ghobrial has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Predicta Biosciences . Dr. Ghobrial has received personal compensation in the range of $10,000-$49,999 for serving as a Speaker, Presenter with Regeneron . |
| Markus Mapara, MD, PhD |
Dr. Mapara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OSSIUM. |
| Mario Gil |
No disclosure on file
|
| Yi Lin |
No disclosure on file
|
| Melinda Tan |
No disclosure on file
|
| Akshara Balachandra, MD |
The institution of Dr. Balachandra has received research support from National Institutes of Health. |
| Josep O. Dalmau, MD, PhD, FAAN |
Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas Research Institute of America. Dr. Dalmau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Research & Development . Dr. Dalmau has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. An immediate family member of Dr. Dalmau has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Dalmau has received research support from Sage Therapeutics. The institution of Dr. Dalmau has received research support from Edmond J.Safra Foundation . The institution of Dr. Dalmau has received research support from La Caixa Foundation. The institution of Dr. Dalmau has received research support from Spanish Ministry of Health (ISCIII). The institution of Dr. Dalmau has received research support from Euroimmun, Inc. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Dalmau has received intellectual property interests from a discovery or technology relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. Dr. Dalmau has received publishing royalties from a publication relating to health care. |
| Michael R. Wilson, MD, FAAN |
Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ouro Medicines. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Indapta Therapeutics. Dr. Wilson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Delve Bio. Dr. Wilson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cambridge Medical Experts. Dr. Wilson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dunham Hallmark. Dr. Wilson has stock in Delve Bio. The institution of Dr. Wilson has received research support from Genentech / Roche. The institution of Dr. Wilson has received research support from NIH. The institution of Dr. Wilson has received research support from Novartis. The institution of Dr. Wilson has received research support from National Multiple Sclerosis Society. The institution of Dr. Wilson has received research support from Fanconi Anemia Research Foundation. The institution of Dr. Wilson has received research support from Department of Defense. The institution of Dr. Wilson has received research support from Chan Zuckerberg Initiative. The institution of Dr. Wilson has received research support from Kyverna Therapeutics. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received intellectual property interests from a discovery or technology relating to health care. Dr. Wilson has received personal compensation in the range of $10,000-$49,999 for serving as a Expert Witness with US Dept of Justice. |
| Thais Armangue, MD |
Dr. Armangue has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Armangue has received research support from ISCIII(Spanish institute of health) -PI21/00316, Marato TV3, La Caixa Research Foundadion, Pablove Foundation (689368), Torrons Vicens Foundation (PFNR0144), 2021 Invest AEP. |
| Maarten J. Titulaer, MD, PhD, FAAN |
The institution of Dr. Titulaer has received research support from Dutch Epilepsy Foundations (NEF 19-08). The institution of Dr. Titulaer has received research support from CSL Behring. The institution of Dr. Titulaer has received research support from UCB. The institution of Dr. Titulaer has received research support from Netherlands Organisation for Scientific Research (ZonMW, Memorabel initiative and E-RARE UltraAIE) . The institution of Dr. Titulaer has received research support from Amgen. The institution of Dr. Titulaer has received research support from Dioraphte (charity). The institution of Dr. Titulaer has received research support from Guidepoint Global LLC. The institution of Dr. Titulaer has received research support from ArgenX. The institution of Dr. Titulaer has received research support from ItsME, patient charity foundation. The institution of Dr. Titulaer has received research support from Erasmus Trustfonds. The institution of Dr. Titulaer has received research support from Erasmus MC Foundation. Dr. Titulaer has received intellectual property interests from a discovery or technology relating to health care. Dr. Titulaer has received publishing royalties from a publication relating to health care. |
| Harald Pruess |
Harald Pruss has nothing to disclose. |
| Emmanuel Mignot, MD, PhD |
Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Mignot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharmaceuticals, Inc. . Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for EcoR1. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for ApneaCo. Dr. Mignot has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai Pharmaceuticals. Dr. Mignot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Centessa . |
| Livia A. Dutra, MD |
Dr. Dutra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Dutra has received research support from Hospital Israelita Albert Einstein. The institution of Dr. Dutra has received research support from Laboratório Fleury. Dr. Dutra has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. |
| Eyal Muscal |
Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer. |
| Russell Dale |
Mr. Dale has nothing to disclose. |
| Carsten Finke, MD |
Carsten Finke, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. The institution of Carsten Finke, MD has received research support from Euroimmun. |
| Jose J. Flores-Rivera, MD |
Dr. Flores-Rivera has nothing to disclose. |
| Enrique Gomez Figueroa, MD, MSc |
Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM. |
| Anna Bastiaansen |
Anna Bastiaansen has nothing to disclose. |
| Greer Waldrop, MD |
Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Waldrop has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Bruna de Freitas Dias, MD |
Dr. Dias has nothing to disclose. |
| Anne-Laurie Pinto |
Anne-Laurie Pinto has nothing to disclose. |
| Sergio Muniz-Castrillo, MD, PhD |
Dr. Muniz-Castrillo has nothing to disclose. |
| Frank Leypoldt, MD |
Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Frank Leypoldt, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Frank Leypoldt, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Frank Leypoldt, MD has received research support from German Ministry of Research BMBF. |
| GERALDINE PICARD, MSc |
Mrs. PICARD has nothing to disclose. |
| Adam Al-Diwani, MBBS, PhD |
Dr. Al-Diwani has nothing to disclose. |
| Hannah F. Jones, MBBS, PhD, FRACP |
Dr. Jones has received research support from Health Research Council of New Zealand. Dr. Jones has received research support from Neurological Foundation. |
| Eric Yu, PhD |
Dr. Yu has nothing to disclose. |
| Ivan K. Chinn, MD |
The institution of Dr. Chinn has received research support from National Institutes of Health. Dr. Chinn has received publishing royalties from a publication relating to health care. |
| Gregor Kuhlenbäumer |
No disclosure on file
|
| Graciela Ordoñez-Lozano |
No disclosure on file
|
| Christopher J. Klein, MD, FAAN |
Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. |
| Pranjal Gupta, MD |
Dr. Gupta has nothing to disclose. |
| Mohammad Naseem, MBBS |
Dr. Naseem has nothing to disclose. |
| Sanjana Bhaskar |
Mrs. Bhaskar has nothing to disclose. |
| Marianna Spatola, MD, PhD, FAAN |
The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil. |
| Chiara Milano, MD |
Dr. Milano has nothing to disclose. |
| Laura Marmolejo Alcaide |
Miss Marmolejo Alcaide has nothing to disclose. |
| Jesus Planaguma |
Dr. Planaguma has nothing to disclose. |
| Esther Aguilar, Bachelor of science |
Mrs. Aguilar has nothing to disclose. |
| Jerome Honnorat, MD, PhD |
Jerome Honnorat, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB. The institution of Jerome Honnorat, MD, PhD has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for journal of neurology. |
| Francesc R. Graus, MD |
Dr. Graus has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Graus has received intellectual property interests from a discovery or technology relating to health care. |
| Jordi Bruna |
Jordi Bruna has nothing to disclose. |
| Antonio Farina |
Mr. Farina has nothing to disclose. |
| Macarena Villagran-Garcia, MD |
Dr. Villagran-Garcia has received research support from Fundación Martín Escudero. |
| Prajwal Ciryam, MD, PhD |
The institution of Dr. Ciryam has received research support from Henry M. Jackson Foundation. The institution of Dr. Ciryam has received research support from Passano Foundation. The institution of Dr. Ciryam has received research support from GEn1E Lifesciences. The institution of Dr. Ciryam has received research support from Brain Aneurysm Foundation. The institution of Dr. Ciryam has received research support from Neurocritical Care Foundation. The institution of Dr. Ciryam has received research support from Center for Shock, Trauma, and Anesthesiology Research, University of Maryland. |
| Timothy Zhang |
Timothy Zhang has nothing to disclose. |
| Audrey Lawrence |
Ms. Lawrence has nothing to disclose. |
| Niki Gooya, PhD |
Dr. Gooya has nothing to disclose. |
| Charles Dean |
Mr. Dean has nothing to disclose. |
| Thanh Hien T. Vu |
Ms. Vu has nothing to disclose. |
| Yuyoung Joo, PhD |
Dr. Joo has nothing to disclose. |
| Maureen A. Kane, PhD |
Prof. Kane has nothing to disclose. |
| Scott K. Dessain, MD, PhD |
Dr. Dessain has nothing to disclose. |
| Weiliang Huang |
No disclosure on file
|
| Jeffrey M. Gelfand, MD, MS, FAAN |
Dr. Gelfand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Arialys. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ventyx Bio. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache: The Journal of Head and Face Pain. The institution of Dr. Gelfand has received research support from Genentech/Roche. The institution of Dr. Gelfand has received research support from Vigil Neurosciences. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has received publishing royalties from a publication relating to health care. Dr. Gelfand has a non-compensated relationship as a Trial Steering Committee Chairperson and member with Roche / Genentech that is relevant to AAN interests or activities. |
| Denis T. Balaban, MD |
Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Infucare. Dr. Balaban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedLive. The institution of Dr. Balaban has received research support from ArgenX. |
| Shruti P. Agnihotri, MD |
An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech. |
| Zachery Rohm, MD |
Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rohm has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Rohm has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for City of Chicago. |
| Yoji Hoshina, MD |
Dr. Hoshina has nothing to disclose. |
| Joao Vitor Mahler, MD |
Dr. Mahler has received research support from The Sumaira Foundation. |
| Conor Kelly, MD |
Dr. Kelly has nothing to disclose. |
| Avi Singh Gandh, MD |
Dr. Gandh has nothing to disclose. |
| Bruna Leles Vieira de Souza, MD |
Miss Leles Vieira de Souza has nothing to disclose. |
| Ashley T. Lisbeth, PA |
Ms. Lengel has nothing to disclose. |
| Elijah Lackey, MD |
Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Lackey has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lackey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Doximity. |
| Andrea Mendez Colmenares, MD, PhD |
Dr. Mendez Colmenares has nothing to disclose. |
| Jeffrey Shen |
Jeffrey Shen has nothing to disclose. |
| Michelle M. Maher, MD |
Dr. Maher has nothing to disclose. |
| Ari Green, MD |
Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from Department of Defense. The institution of Dr. Green has received research support from NIH. The institution of Dr. Green has received research support from NIH / NINDS. The institution of Dr. Green has received research support from NIH / NINDS. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. |
| Priya Dhawan, MD |
Dr. Dhawan has nothing to disclose. |
| Sasha Gupta, MD |
Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Legend . Dr. Gupta has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| Ahmed Abdelhak, MD |
The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society. |
| Leonie Muller-Jensen, MD |
Dr. Muller-Jensen has received personal compensation in the range of $0-$499 for serving as a Compensation for invited lecture with AAN. |
| Michelle A. Hughes, BS |
Ms. Hughes has nothing to disclose. |
| Camille Fouassier |
Mrs. Fouassier has nothing to disclose. |
| Jodi Lipof, MD |
Dr. Lipof has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kite/arcellx. Dr. Lipof has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. |
| Taylor Hill |
Miss Hill has nothing to disclose. |
| Omar Hernandez |
Mr. Hernandez has nothing to disclose. |
| Bonell Patino-Escobar, MD |
Dr. Patino-Escobar has nothing to disclose. |
| Arun Wiita, MD, PhD |
Dr. Wiita has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Wiita has or had stock in Seen Therapeutics. |
| shagun arora, MD |
Dr. arora has nothing to disclose. |
| Peter H. Sayre, MD, PhD |
Dr. Sayre has nothing to disclose. |
| Serena S. Kwek, PhD |
Dr. Kwek has nothing to disclose. |
| David Oh, MD, PhD |
Dr. Oh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revelation Partners. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tatum Biosciences. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartography Biosciences. The institution of Dr. Oh has received research support from Merck Sharp Dohme. The institution of Dr. Oh has received research support from PACT Pharma. The institution of Dr. Oh has received research support from Poseida Therapeutics. The institution of Dr. Oh has received research support from TCR2 Therapeutics. The institution of Dr. Oh has received research support from Roche/Genentech. The institution of Dr. Oh has received research support from Nutcracker Therapeutics. The institution of Dr. Oh has received research support from Amgen. The institution of Dr. Oh has received research support from Allogene. The institution of Dr. Oh has received research support from Clasp Therapeutics. The institution of Dr. Oh has received research support from Janux Therapeutics. Dr. Oh has received intellectual property interests from a discovery or technology relating to health care. |
| Jun Yan He |
Mr. He has nothing to disclose. |
| Jeffrey L. Wolf, MD |
Dr. Wolf has nothing to disclose. |
| Ajai Chari, MD |
Dr. Chari has received personal compensation for serving as an employee of UCSF. Dr. Chari has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for abbvie. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for adaptive. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amgen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Antegene. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Forus. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Chari has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karyopharm. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Chari has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Chari has received research support from Janssen. |
| Thomas Martin, MD |
Dr. Martin has received personal compensation for serving as an employee of GSK. Dr. Martin has received personal compensation for serving as an employee of Lilly. Dr. Martin has received personal compensation for serving as an employee of Pfizer. Dr. Martin has received personal compensation for serving as an employee of AstraZeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for astrazeneca. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for gsk. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for pfizer. Dr. Martin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Martin has received research support from sanofi. Dr. Martin has received research support from janssen. Dr. Martin has received research support from BMS. |
| Alfred Chung, MD |
Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson Innovative Medicine. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers-Squibb. The institution of Dr. Chung has received research support from Abbvie. The institution of Dr. Chung has received research support from Bristol Myers Squibb. The institution of Dr. Chung has received research support from Caelum Biosciences. The institution of Dr. Chung has received research support from CARsgen Therapeutics. The institution of Dr. Chung has received research support from Johnson and Johnson Innovative Medicine . The institution of Dr. Chung has received research support from K36 Therapeutics . |
| Darren Pan, MD |
Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson and Johnson. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Pan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. |
| Anupama D. Kumar, MD |
Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Legend. The institution of Dr. Kumar has received research support from Astrazeneca. The institution of Dr. Kumar has received research support from Bristol Myers Squibb. The institution of Dr. Kumar has received research support from Celgene. |
| Donald Langan, Jr., MD |
Dr. Langan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. |
| David Sabatino, PharmD |
Dr. Sabatino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. |
| Lakshman N. Arcot Jayagopal, MD |
Dr. Arcot Jayagopal has nothing to disclose. |